Advanced search
Publication Cover
Journal of Dermatological Treatment Volume 21, 2010 - Issue 5
Submit an article Journal homepage
1,447
Views
1
CrossRef citations to date
0
Altmetric
Letters

A case of herpes zoster during pimecrolimus use for the treatment of subacute cutaneous lupus erythematosus

Semih Tatlican Dermatology Department, Ministry of Health Diskapi Yildirim Beyazit Education and Research Hospital, Ankara, TurkeyCorrespondence[email protected]
,
Cemile Eren Dermatology Department, Ministry of Health Diskapi Yildirim Beyazit Education and Research Hospital, Ankara, Turkey
,
Damla Atacan Dermatology Department, Ministry of Health Diskapi Yildirim Beyazit Education and Research Hospital, Ankara, Turkey
,
Umut Dalgic Dermatology Department, Ministry of Health Diskapi Yildirim Beyazit Education and Research Hospital, Ankara, Turkey
,
Filiz Canpolat Dermatology Department, Ministry of Health Diskapi Yildirim Beyazit Education and Research Hospital, Ankara, Turkey
&
Fatma Eskioglu Dermatology Department, Ministry of Health Diskapi Yildirim Beyazit Education and Research Hospital, Ankara, Turkey
Pages 322-323 | Received 13 Jun 2009, Accepted 05 Aug 2009, Published online: 16 Oct 2009

References

  • Sehgal VN, Pahwa M. Pimecrolimus, yet another intriguing topical immunomodulator. J Dermatolog Treat. 2007;18:147–150.
  • Liesegang TJ. Herpes zoster ophthalmicus natural history, risk factors, clinical presentation, and morbidity. Ophthalmology. 2008;115(2 suppl):S3–S12.
  • Sontheimer RD. Subacute cutaneous lupus erythematosus: 25-year evolution of a prototypic subset (subphenotype) of lupus erythematosus defined by characteristic cutaneous, pathological, immunological, and genetic findings. Autoimmun Rev. 2005;4:253–263.
  • Tzellos TG, Kouvelas D. Topical tacrolimus and pimecrolimus in the treatment of cutaneous lupus erythematosus: An evidence-based evaluation. Eur J Clin Pharmacol. 2008;64:337–341.
  • Wollina U, Hansel G. The use of topical calcineurin inhibitors in lupus erythematosus: An overview. J Eur Acad Dermatol Venereol. 2008;22:1–6.
  • Barikbin B, Givrad S, Yousefi M, Eskandari F. Pimecrolimus 1% cream versus betamethasone 17-valerate 0.1% cream in the treatment of facial discoid lupus erythematosus: A double-blind, randomized pilot study. Clin Exp Dermatol. Epub 2009 May 18.
  • Tlacuilo-Parra A, Guevara-Gutiérrez E, Gutiérrez-Murillo F, Soto-Ortiz A, Barba-Gómez F, Hernández-Torres M, Pimecrolimus 1% cream for the treatment of discoid lupus erythematosus. Rheumatology (Oxford). 2005;44:1564–1568.
  • Kreuter A, Gambichler T, Breuckmann F, Pawlak FM, Stücker M, Bader A, Pimecrolimus 1% cream for cutaneous lupus erythematosus. J Am Acad Dermatol. 2004;51:407–410.
  • Luger TA, Lahfa M, Fölster-Holst R, Gulliver WP, Allen R, Molloy S, Longterm safety and tolerability of pimecrolimus cream 1% and topical corticosteroids in adults with moderate to severe atopic dermatitis. J Dermatolog Treat. 2004;15:169–178.
  • Ashcroft DM, Dimmock P, Garside R, Stein K, Williams HC. Efficacy and tolerability of topical pimecrolimus and tacrolimus in the treatment of atopic dermatitis: Meta analysis of randomized controlled trials. BMJ. 2005;330:516.
  • Paul C, Cork M, Rossi AB, Papp KA, Barbier N, de Prost Y. Safety and tolerability of 1% pimecrolimus cream among infants: Experience with 1133 patients treated for up to 2 years. Pediatrics. 2006;117:118–128.
  • Mossman KL. Activation and inhibition of virus and interferon: The herpes virus story. Viral Immunol. 2002;15:3–15.
  • Kang I, Park SH. Infectious complications in SLE after immunosuppressive therapies. Curr Opin Rheumatol. 2003;15:528–534.
  • Ishikawa O, Abe M, Miyachi Y. Herpes zoster in Japanese patients with systemic lupus erythematosus. Clin Exp Dermatol. 1999;24:327–328.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.